NorthWest Biotherapeutics Inc (NWBO)

[jimmy667]

Nice post Doctor. An FDA or other regulatory approval does not equal wide spread adoption. If a Company has a tool then first they need to convince the users of the tool that it has utility. So ultimately the goal is to convince the front line of Oncology Care Providers that the tool has utility. Therefore the Journal Article is paramount whether or not it comes before or after regulatory approval. Regulatory approval does not make something "State of the Art" but rather the the adoption of the Art by the Artists makes it so. Regulatory approval is crucial but adoption by Physicians is where the "Rubber Meets the Road." Why file for regulatory approval before those that will use it are asking access to this new technology. The Journal Article while not necessary for approval is crucial for adoption of the technology.